scholarly journals Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment

Cureus ◽  
2019 ◽  
Author(s):  
Abdul Razaq ◽  
Safeera Khan ◽  
Junaid Hassan ◽  
Bilal Haider Malik ◽  
Mahrukh Razaq
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Efficacy And Safety ◽  
Mineral Density ◽  
Antihormonal Treatment

Evaluation with densitometry of patients with breast cancer and low bone mineral density after 2 years of treatment

2013 ◽  
Author(s):  
Sonia Munoz Gil ◽  
Tomas Mut Dolera ◽  
Belen C Garrido Lopez ◽  
M D Torregrosa Maicas ◽  
R Girones Sarrio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Mineral Density ◽  
Low Bone Mineral Density

Effects of One-Year Adjuvant Treatment with Tamoxifen on Bone Mineral Density in Postmenopausal Breast Cancer Women

1996 ◽  
Vol 82 (1) ◽  
pp. 65-67 ◽  
Author(s):  
Sandro Barni ◽  
Paolo Lissoni ◽  
Gabriele Tancini ◽  
Antonio Ardizzoia ◽  
Marina Cazzaniga
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Adjuvant Treatment ◽  
Mineral Content ◽  
Postmenopausal Breast Cancer ◽  
Mineral Density ◽  
One Year

In this study, the authors have analyzed the possible effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women. Bone mineral content was studied by photon absorptiometry (I-125), whereas bone balance was analyzed indirectly by serum PTH, osteocalcin, calcitonin, calcium and alkaline phosphatase levels. Bone mineral content and serum bone-related substances were measured before starting treatment and after one year. Results were analyzed using Student's t test for paired data. No difference was found between the two measurements for bone mineral content, PTH, calcitonin, calcium and alkaline phosphatase levels. Measurements at entry and after one year of treatment showed a statistically significant difference ( P < 0.001) only for osteocalcin. In accordance with other authors, we can conclude that treatment with tamoxifen does not cause an increase in menopausal bone resorption. The finding that osteocalcin levels decreased after one year of therapy with tamoxifen is interesting, but further studies are necessary to clarify the role of such levels in predicting a turnover of bone balance towards osteoblastic activity.

scholarly journals Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer

2009 ◽  
Vol 103 (6) ◽  
pp. 753-757 ◽  
Author(s):  
Abbas H. Panju ◽  
Henriette Breunis ◽  
Angela M. Cheung ◽  
Marc Leach ◽  
Neil Fleshner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Mineral Density ◽  
Androgen Deprivation Therapy ◽  
Bone Mineral ◽  
Androgen Deprivation ◽  
Mineral Density

Bone mineral density in Brazilian Midwest women recently diagnosed with breast cancer: A case-control study

2018 ◽  
Vol 92 ◽  
pp. S50
Author(s):  
R. De Freitas Junior ◽  
L.V. Gonçalves ◽  
R.M. Schingaglia ◽  
J. Godinho-Mota ◽  
K.A. Martins ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Case Control Study ◽  
Case Control ◽  
Mineral Density ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document